中裕

-1.80 (-2.92%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

59.80826成交張數–本益比4.40股價淨值比0.00%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	45	37	18.3%	15.48	13.46	-3.7%	-3.0%	0.6	0.4
2026Q1	46	38	18.1%	16.83	13.90	-3.2%	-2.6%	-0.5	-0.5
2025Q4	48	39	19.8%	13.11	14.12	-4.3%	-3.4%	0.3	0.3
2025Q3	48	39	18.6%	18.84	14.36	-5.5%	-4.2%	1.2	1.2
2025Q2	48	39	18.3%	24.39	14.35	-6.0%	-4.9%	0.0	0.0
2025Q1	49	40	18.7%	24.12	14.67	-5.1%	-4.1%	0.5	0.4
2024Q4	50	40	19.5%	25.18	14.73	-6.1%	-4.5%	-5.1	-5.1
2024Q3	57	41	27.7%	5.66	15.19	-4.2%	-2.9%	0.5	0.5
2024Q2	52	42	20.1%	25.38	15.34	-3.2%	-2.4%	0.5	0.5
2024Q1	55	42	23.3%	11.53	15.42	-3.8%	-2.7%	0.3	0.3
2023Q4	39	26	34.1%	5.96	10.14	-7.4%	-4.9%	0.3	0.3
2023Q3	40	26	33.9%	6.05	10.45	-6.4%	-4.1%	0.1	0.1
2023Q2	40	26	34.1%	6.34	10.46	-7.5%	-4.8%	0.2	0.1
2023Q1	40	26	34.5%	6.84	10.47	-8.4%	-5.3%	-0.8	-0.8
2022Q4	41	27	33.8%	6.56	10.75	-9.5%	-6.2%	-0.0	-0.0
2022Q3	45	27	38.3%	7.93	10.88	-17.7%	-11.5%	-0.3	-0.3
2022Q2	45	28	38.1%	8.60	10.97	-18.8%	-12.3%	-4.4	-4.4
2022Q1	47	28	40.1%	5.40	11.24	-19.0%	-12.2%	-1.3	-1.3
2021Q4	46	29	36.2%	10.37	11.66	-14.8%	-9.6%	0.8	0.8
2021Q3	48	33	32.2%	23.15	12.91	-7.8%	-5.3%	-0.1	-0.1
2021Q2	49	33	31.6%	10.64	13.20	-6.8%	-4.5%	-0.2	-0.2
2021Q1	50	34	31.7%	9.54	13.58	-3.0%	-2.1%	-2.6	-2.7
2020Q4	52	34	34.3%	6.02	13.54	-5.2%	-3.7%	0.6	0.5
2020Q3	52	35	32.7%	7.47	13.92	-4.8%	-3.4%	-0.0	0.5
2020Q2	54	36	33.7%	6.33	14.09	-11.9%	-8.7%	-2.4	-3.3
2020Q1	50	35	29.6%	3.36	13.95	-14.9%	-11.6%	-0.2	-0.2
2019Q4	47	36	24.2%	5.74	14.22	-15.1%	-12.2%	-3.6	-2.9
2019Q3	49	37	25.7%	4.48	14.53	-16.5%	-13.3%	-2.0	-2.8
2019Q2	50	40	20.2%	6.04	15.79	-16.1%	-13.4%	-0.1	-0.4
2019Q1	47	41	13.6%	18.57	16.09	-12.7%	-11.2%	-0.9	-1.3
2018Q4	48	41	14.8%	10.68	16.23	-7.7%	-6.9%	-1.6	-3.6
2018Q3	48	42	13.2%	14.89	16.76	-7.7%	-7.1%	-2.3	-2.7
2018Q2	52	45	12.9%	12.50	18.10	-1.8%	-1.6%	-0.2	-5.0
2018Q1	49	44	10.2%	9.78	17.64	-7.0%	-6.5%	-1.2	-1.5
2017Q4	45	43	4.7%	37.11	17.15	-11.7%	-11.3%	-1.7	-3.9
2017Q3	47	45	4.1%	53.05	17.82	-10.1%	-9.8%	-2.2	-2.7
2017Q2	49	46	6.3%	22.61	18.26	-8.7%	-8.4%	-0.5	-0.5
2017Q1	48	47	3.5%	88.03	18.69	-6.4%	-6.3%	-0.8	-0.9
2016Q4	48	47	1.8%	73.67	18.86	–	–	-0.5	-0.6
2016Q3	48	48	0.9%	269.52	19.27	–	–	-0.4	-0.4